Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Pronorvista on Oct 27, 2023 1:32pm

ATE

Much less pressure.


Market By Price

Price Total Volume Value
0.750 6,000 $4,500
0.740 2,500 $1,850
0.730 11,250 $8,212
0.710 20,000 $14,200
0.700 3,000 $2,100
0.690 4,000 $2,760
0.680 4,500 $3,060
0.660 15,000 $9,900
0.650 8,500 $5,525
0.640 500 $320
0.620 1,000 $620
0.610 8,000 $4,880
0.600 16,500 $9,900
0.580 44,500 $25,808
0.570 25,000 $14,248
0.560 27,800 $15,568
0.550 10,500 $5,775
0.540 10,000 $5,400
0.530 22,000 $11,660
0.520 9,000 $4,680
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities